Table 3. Stratified analyses of the rs2853676 polymorphism in lung adenocarcinoma.

Author(year)	Ethnicity	Cancer type	Source	Method	Cases/Controls	OR (95%CI)
Hsiung et al. (2010)	Asian	Adenocarcinoma	Multiple	Illumia	1930/2535	1.06(0.95–1.19)
Zhao et al. (2013)	Asian	Adenocarcinoma	PB	SNPscan	359/778	1.04(0.83–1.31)
Park et al. (MEC 2014)	Multiple	Adenocarcinoma	Multiple	Illumia	252/9587	1.19(0.96–1.47)
Park et al. (WHI 2014)	Multiple	Adenocarcinoma	Multiple	Illumia	760/5825	1.11(0.98–1.25)
Park et al. (DeCode Genetics 2014)	Caucasian	Adenocarcinoma	PB	Illumia	346/11225	1.03(0.86–1.22)
Park et al. (Harvard 2014)	Caucasian	Adenocarcinoma	PB	Illumia	488/970	1.26(1.06–1.51)
Park et al. (HGF Germany 2014)	Caucasian	Adenocarcinoma	PB	Illumia	188/479	1.18(0.84–1.67)
Park et al. (IARC GWAS 2014)	Multiple	Adenocarcinoma	Multiple	Illumia	586/3174	1.25(1.08–1.44)
Park et al. (MDACC 2014)	Caucasian	Adenocarcinoma	Multiple	Illumia	619/1133	1.09(0.93–1.28)
Park et al. (NCI GWAS 2014)	Multiple	Adenocarcinoma	Multiple	Illumia	1836/5686	1.19(1.09–1.29)
Park et al. (SLRI/ Toronto 2014)	Caucasian	Adenocarcinoma	PB	Illumia	89/488	1.07(0.76–1.51)

PB: Population based; HB: Hospital based;

The overall OR = 1.14, 95% CI: 1.09–1.19, P <0.001; P _{heterogeneity} = 0.616, I ² = 0.0%.